Showing results (2011-2020 of 2,070) with videos related to
Sort By:
Pageof 207
Stroke|January 30, 2020
Endovascular Stroke Treatment and Risk of Intracranial Hemorrhage in Anticoagulated PatientsThomas R Meinel, Joachim U Kniepert, David J Seiffge, et al.Plos One|October 21, 2014
Avian influenza virus (H11N9) in migratory shorebirds wintering in the Amazon Region, BrazilJansen de Araujo, Severino M de Azevedo, Nicolas Gaidet, et al.Plos Neglected Tropical Diseases|June 15, 2026
Comparison of a recombinant endonuclease III protein and its synthetic peptides in ELISA for the diagnosis of tegumentary leishmaniasis using human serum and urine samples: A preliminary studyRaquel S B Câmara, Dóris M Abrão, Daniela P Lage, et al.Intensive Care Medicine|October 1, 2016
The effects of performance status one week before hospital admission on the outcomes of critically ill patientsFernando G Zampieri, Fernando A Bozza, Giulliana M Moralez, et al.ACS Chemical Neuroscience|December 4, 2023
Neuroprotective Profile of Triazole Grandisin Analogue against Amyloid-Beta Oligomer-Induced Cognitive ImpairmentVictor H B de Andrade, Erick Y M Rodrigues, Nayara A F Dias, et al.Gut|September 10, 2020
TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanismsAitor Esparza-Baquer, Ibone Labiano, Omar Sharif, et al.Environment International|September 26, 2020
Belowground changes to community structure alter methane-cycling dynamics in AmazoniaKyle M Meyer, Andrew H Morris, Kevin Webster, et al.Acta Tropica|August 2, 2025
Polymeric micelles loaded with a 1,2,3-triazolium derivative: a promising strategy against tegumentary leishmaniasisCamila S Freitas, Daniela P Lage, Breno L Pimenta, et al.Parasitology International|December 2, 2025
Recombinant small myristoylated protein-3 and synthetic peptide as diagnostic and prognostic biomarkers for tegumentary leishmaniasisMaíza M Rodrigues, Raquel S B Câmara, Camila S Freitas, et al.Pathogens (Basel, Switzerland)|December 31, 2025
Immunotherapeutics Combining a Recombinant Chimeric Protein, Monophosphoryl Lipid A, and Miltefosine Against Visceral LeishmaniasisMarcelo M Jesus, Daniela P Lage, Breno L Pimenta, et al.Pageof 207